European Urology - Residual Tumour Resection Following Inductive Chemotherapy in Advanced Testicular Cancer
Thursday, 01 February 2007
Volume 51, Issue 2, Pages 299-301 (February 2007) Surgical resection of postchemotherapy residual retroperitoneal lymph nodes or residual visceral metastatic deposits represents an integral part of the multimodality treatment for patients with advanced testicular cancer undergoing inductive systemic chemotherapy [1].
read more
|
TC Incidence Increasing: Spread the Word
Sunday, 11 February 2007
Volume 51, Issue 3, Pages 596-597 (March 2007)
Worldwide, the incidence of testicular cancer (TC) has more than doubled over the last 30–40 yr; similarly, a parallel increase in TC has occurred in Europe, as shown by this excellent review [1].
read more
|
European Urology - Failure of High-Dose Cyclophosphamide and Etoposide Combined with Double-Dose Cisplatin and Bone Marrow Support in Patients with High-Volume Metastatic Nonseminomatous Germ-Cell Tumours: Mature Results of a Randomised Trial
Thursday, 01 March 2007
Volume 51, Issue 3, Pages 739-748 (March 2007)
Abstract -
Objectives:
To assess the impact on survival of high-dose chemotherapy with haematopoietic support in patients with high-volume, metastatic nonseminomatous germ cell tumours.
read more
|
European Urology - Diagnosis of Contralateral Testicular Intraepithelial Neoplasia (TIN) in Patients with Testicular Germ Cell Cancer: Systematic Two-Site Biopsies Are More Sensitive Than a Single Random Biopsy
Friday, 05 January 2007
Volume 51, Issue 1, Pages 175-185 (January 2007) Abstract - Objectives: Searching for testicular intraepithelial neoplasia (TIN; carcinoma in situ) in the contralateral testis of patients with germ cell tumour (GCT) may early disclose contralateral GCT.
read more
|
European Urology - Predicting Retroperitoneal Histology in Postchemotherapy Testicular Germ Cell Cancer: A Model Update and Multicentre Validation with More Than 1000 Patients
Thursday, 01 February 2007
Volume 51, Issue 2, Pages 424-432 (February 2007) 1. Introduction: Cisplatin-based chemotherapy is highly effective as treatment of advanced nonseminomatous testicular germ cell cancer. Surgical resection after chemotherapy is a standard approach to remove enlarged (≥10mm) retroperitoneal lymph nodes.
read more
|
European Urology - Testicular Cancer Variations in Time and Space in Europe
Tuesday, 13 February 2007
Volume 51, Issue 3, Pages 621-628 (March 2007)
1. Introduction
Testicular cancer (TC) is the most common cancer in young men aged 20–34 yr and represents about 1% of all tumours in men.
read more
|
European Urology - Management of Stage I Testis Cancer
Monday, 01 January 2007
Volume 51, Issue 1, Pages 34-44 (January 2007)
Abstract -
Objective:
Over the last 5 years the management of stage I testis cancer has changed tremendously. This review focuses on the latest changes in diagnostics and treatment of clinical stage I non-seminomatous and seminomatous germ cell tumors.
read more
|
